MoF issued regarding the declaration of certain Nitazene Derivatives as Manufactured Drugs

Feb 25, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Ministry of Finance (MoF) on February 18, 2026, issued the notification regarding the declaration of certain Nitazene Derivatives as Manufactured Drugs under the NDPS Act, 1985

The following has been stated namely: -

• In exercise of its powers under Section 2(xi)(b), certain specified substances have been declared as “manufactured drugs.”

• The substances notified include:

o N-Pyrrolidino protonitazene (protonitazepyne)

o N-pyrrolidino metonitazene (metonitazepyne)

o Etonitazepipne (N-piperidinyl etonitazene)

o N-Desethyl-isotonitazene (norisotonitazene)

• The declaration covers the substances along with their salts and preparations.

The notification will come into effect from February 18, 2026.

[Notification No. S.O. 905(E)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT